Insiders / Edwards Martin
Edwards Martin
CIK 1640073personinsider
Companies
5
First seen
Jan 4, 2021
Last activity
Oct 8, 2025
Companies
| Company | Shares held | Latest |
|---|---|---|
| Inozyme Pharma, Inc. · INZY | — | — |
| KalVista Pharmaceuticals, Inc. · KALV | — | — |
| Morphic Holding, Inc. · MORF | — | — |
| Reata Pharmaceuticals Inc · RETA | — | — |
| Verona Pharma plc · RNA | — | — |
All securities held
4 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Morphic Holding, Inc. | Common stock | 23,168 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Inozyme Pharma, Inc. | Options | 28,000 |
| KalVista Pharmaceuticals, Inc. | Options | 10,000 |
Other
| Company | Security | Shares |
|---|---|---|
| Verona Pharma plc | Unclassified | 111,064 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jun 7, 2023 | Grant Grant or award | RETA Reata Pharmaceuticals Inc Class A common stock | $157.5K | +2K +37.93% | 6,116 | low |
| Aug 1, 2025 | Sell Open-market sale | RNA Verona Pharma plc Ordinary Shares | $142.1K | -11K -6.40% | 157,992 | medium |
| Jun 8, 2022 | Grant Grant or award | RETA Reata Pharmaceuticals Inc Class A common stock | $135.0K |